Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment

Hereditary forms of medullary thyroid carcinoma (MTC) are rare. Different phenotypes with the same mutation may be due to differences in the timing of rearranged during transfection (RET) activation steps, additional mutations in other regions of the gene, or the co-occurrence of germline and somati...

Полное описание

Библиографические подробности

Главные авторы:	Sirmen Kızılcan Çetin, Zeynep Şıklar, Elif Özsu, Ayşegül Ceran, Koray Ceyhan, Zehra Aycan, Ayça Kırmızı, Handan Dinçaslan, Emel Ünal, Merih Berberoğlu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Pediatric Endocrinology and Diabetes Society 2025-09-01
Серии:	JCRPE
Предметы:	medullary thyroid carcinoma ret sorafenib
Online-ссылка:	https://www.jcrpe.org/articles/familial-clinical-heterogeneity-of-medullary-thyroid-cancer-with-germline-lessemgreaterretlessemgreater-s891a-protooncogene-mutation-7-year-follow-up-with-successful-sorafenib-treatment/doi/jcrpe.galenos.2023.2023-7-13
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!